Related references
Note: Only part of the references are listed.Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH)
M. Hjelkrem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: A favorable endogenous response
Ramesh Kumar et al.
CLINICAL BIOCHEMISTRY (2012)
Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
Federico Salamone et al.
DIGESTIVE AND LIVER DISEASE (2012)
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
Carmela Loguercio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities
Roberto Gambino et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Adipokines and Redox Signaling: Impact on Fatty Liver Disease
Maurizio Parola et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Biliverdin protects against the deterioration of glucose tolerance in db/db mice
N. Ikeda et al.
DIABETOLOGIA (2011)
Non-alcoholic fatty liver disease: what's new under the microscope?
Elizabeth M. Brunt
GUT (2011)
The Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NOX) Homologues NOX1 and NOX2/gp91phox Mediate Hepatic Fibrosis in Mice
Yong-Han Paik et al.
HEPATOLOGY (2011)
Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease
Jing-Ping Lin et al.
CLINICAL CHEMISTRY (2010)
Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice
Jun Yu et al.
GASTROENTEROLOGY (2010)
Role and Cellular Source of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Hepatic Fibrosis
Samuele De Minicis et al.
HEPATOLOGY (2010)
Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase
Masakazu Fujii et al.
KIDNEY INTERNATIONAL (2010)
Curcumin limits the fibrogenic evolution of experimental steatohepatitis
Francesco Vizzutti et al.
LABORATORY INVESTIGATION (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules
Graciela Lujan Mazzone et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Histopathology of Non-Alcoholic Fatty Liver Disease
Elizabeth M. Brunt
CLINICS IN LIVER DISEASE (2009)
Bilirubin and glutathione have complementary antioxidant and cytoprotective roles
Thomas W. Sedlak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury
G. Serviddio et al.
GUT (2008)
Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome
Zeki Yesilova et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes
Michiaki Fukui et al.
KIDNEY INTERNATIONAL (2008)
Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes
Toyoshi Inoguchi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study
Jing-Ping Lin et al.
CIRCULATION (2006)
Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications
SW Ryter et al.
PHYSIOLOGICAL REVIEWS (2006)
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
LA Videla et al.
CLINICAL SCIENCE (2004)
In vivo anti-complement effect of bilirubin-IXα
SM Arriaga et al.
BIOCHEMICAL PHARMACOLOGY (2002)
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
S Seki et al.
JOURNAL OF HEPATOLOGY (2002)
A model-based method for assessing insulin sensitivity from the oral glucose tolerance test
A Mari et al.
DIABETES CARE (2001)
Share Paper
